CCR3 antagonists (Millennium/Roche)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCCR3 antagonists (Millennium/Roche)
Drug Alias NameCCR3 antagonist (LeukoSite)eosinophil inhibitors (Millennium)eosinophil inhibitors (LeukoSite)eotaxin antagonist (Millennium)7B11 MAb +[14] 
ClassificationSmall molecules
Mechanisms of ActionC-C chemokine receptor type 3 antagonistsChemotactic factor antagonists
TargetsC-C chemokine receptor type 3
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeukosite
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeukositeMillennium Pharmaceuticals IncRoche Palo Alto Llc
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A